Securities Code: 002382 Bond Code: 128108 Securities Abbreviation: Blue Sail Medical Bond Abbreviation: Blue Sail Convertible Bond Announcement Number: 2026-049
Blue Sail Medical Co., Ltd. Announcement on Accruing Asset Impairment Provisions and Disposing of Some Fixed Assets in 2025
The Company and the entire Board of Directors guarantee the authenticity, accuracy, and completeness of the information disclosed, and are free from any false records, misleading statements, or material omissions.
Blue Sail Medical Co., Ltd. (hereinafter referred to as the "Company"), in accordance with the "Accounting Standards for Business Enterprises," the "Shenzhen Stock Exchange Stock Listing Rules," the "Shenzhen Stock Exchange Main Board Listed Company Self-Regulatory Management Guidelines No. 1 - Standardized Operation of Main Board Listed Companies," and other relevant regulations, based on the principle of prudence, has fully assessed and analyzed the possibility of impairment for various assets and accrued corresponding impairment provisions for assets showing signs of impairment; some fixed assets that cannot meet production and operation needs have been disposed of through scrapping. The specific situation is hereby announced as follows:
I. Overview of Asset Impairment Provisions Accrued This Time
- Reasons for Accruing Asset Impairment Provisions This Time
Based on the principle of prudence, to more truthfully and accurately reflect the Company's financial position, asset value, and operating results as of December 31, 2025, in accordance with the "Accounting Standards for Business Enterprises" and the Company's relevant accounting policies, the Company and its subsidiaries have conducted a comprehensive inventory, analysis, and evaluation of various assets, and have accrued impairment provisions for items that may incur credit impairment losses and asset impairment losses.